The PennZone

  • Home
  • Business
  • Health
  • Construction
  • Real Estate
  • Technology
  • Education
  • Travel
  • Marketing

ExpressCells to Present in BIO Start-Up Stadium Next Week
The PennZone/10070540

Trending...
  • Red5 Taps PubNub to Power the Next Era of Real-Time Interactive Streaming
  • LARUS Launches Business Continuity Framework for IPv4-Dependent Networks
  • Shoutout Joseph Neibich aka Nybyk
Company is one of 30 selected for prestigious competition. During BIO Digital Week, attendees can watch timely, on-demand pitches and meet with ExpressCells via BIO's One-on-One Partnering.

PHILADELPHIA - PennZone -- ExpressCells, Inc. (ExpressCells), a privately-owned genetic engineering company that creates knock-in cell lines for drug discovery, will be one of the finalists presenting in the Start-Up Stadium during BIO Digital Week.

"We are honored to be selected by the judges as one of the finalists for Start-Up Stadium. We hope that all BIO Digital Week attendees view our presentation, which will be available on demand via the meeting platform."

Start-Up Stadium provides an exciting and interactive experience where key stakeholders of the early-stage life science community, investors, and strategic partners provide feedback and judge 6 minute pitches presented by start-up biotech companies. During BIO Digital Week, attendees can watch ExpressCells' pitch on-demand and meet with the company via BIO's One-on-One Partnering.

More on The PennZone
  • Burkentine Builders Breaks Ground on Their 100,000-Square-Foot Warehouse in Shippensburg, PA
  • NRx Pharmaceuticals Could Be on the Verge of a Breakout Year as AI, FDA Catalysts, and Mental Health Demand Converge
  • Pine Creek Rail Trail Named Pennsylvania's 2026 Trail of the Year
  • DC Accounting Firm Offers Free Business CRM to Small Business Clients Alongside Weekly Bookkeeping Model
  • CCHR: Psychiatric Drugs Fuel Rising Death Toll: National Adverse Drug Event Awareness Day Confronts America's Medication Crisis

"ExpressCells is excited to be part of BIO Digital Week," Mr. Handel continued. "We hope to gain valuable feedback and to meet with both potential customers and potential investors.

About ExpressCells

ExpressCells is a private biotechnology company based in Philadelphia, PA. Its propriety genome editing technology, in combination with CRISPR/Cas9, creates advanced, knock-in cell line up to 75% faster than older processes. This technology allows ExpressCells to insert up to three genes into the same cell line.

ExpressCells' first knock-in cell lines code for bioluminescent and fluorescent proteins. These allow scientists to more see the results of their experiments in real time. ExpressCells sells both custom cell lines—each designed to meet the specific requirements of an individual scientist—and catalog cell lines. For more information, visit www.xpresscells.com.

Contact
Matthew Handel
***@xpresscells.com
+1 (484) 483-6759


Source: ExpressCells, Inc.

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Homeowner Prep Announces Strategic Language Shift: Replacing "Renters" with "Future Homeowners" to Inspire Wealth-Building Mindsets
  • LiposoMore™ Redefines Bioavailability: Joyful Nutritional Launches High-Performance Liposomal Vitamin C and Iron for the Global Supplement Market
  • GDE Tree Services Expands Operations into Sydney, NSW
  • Tuckwell Machinery Expands CNC Range to Support Australian Cabinet Makers
  • The Inner Power of Emotional Self-Leadership
  • Dr. Nadene Rose Shares the Secret to True Success: Faith, Obedience, and Divine Purpose
  • Best Companies Group Opens Free Registration for Best Places to Work in Insurance Program
  • Understanding Unexpected Death: Why Independent Autopsies Matter in Cases Without Clear Cause
  • Epic Pictures Group Sets North American Release Date for the Thriller NO ORDINARY HEIST
  • Mobile Copywriter Celebrates 13 Years of Content Creation and SEO Services
  • Award-Winning REALTOR® Paige Coker Joins Corcoran DeRonja Real Estate
  • Over 98% of crypto owners globally don't declare taxes, new report find
  • Happreneurs™ Business Community Launches Pittsburgh, PA Chapter with Powerful Network of Founding Leaders
  • TicTac Group acquires French EdTech company Distrisoft
  • Rhys-Davies, Wright, Norris, Jacinto Highlight Latest Wave of FAN EXPO Philadelphia Celebrity Guests
  • Mark Dobosz Makes Donorassess.org Free To Every Nonprofit On The Planet
  • Genpak Announces Closure of Utah Manufacturing Facility
  • Newborn Care Network Introduces Clinical Standard to Bridge the Six-Week Postpartum Gap
  • The AAA Metamorphosis: How Global Gaming Is Redefining Production Standards
  • Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge

Popular on PennZone

  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
  • Conexwest: Shipping Containers Are Powering the Next Generation of Bitcoin Mining Infrastructure
  • Juego Studios Extends Full-Cycle Game Development & Outsourcing Capabilities to the UAE Market
  • Claude Riveloux Review 2026: How the $10B Fund Manager Dispels 'Scam' Rumors Through Education
  • Hope Survives Launches The Hope Collective, A Curated Publication Centering Lived Experience After Brain Injury
  • Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
  • Pure Energy Electrical Services, LLC Announces Strong Start to 2026, Reinforcing Customer-First Electrical Service Across Northeast Florida
  • Cancun Airport Transportation Expands Fleet Ahead of Record Passenger Growth at Cancun International Airport
  • Jack and Sage Acquires Sustainable Apparel Brand Kastlfel, Expanding Premium Logo Wear Across National Parks and Ski Resorts

Similar on PennZone

  • NRx Pharmaceuticals Could Be on the Verge of a Breakout Year as AI, FDA Catalysts, and Mental Health Demand Converge
  • LiposoMore™ Redefines Bioavailability: Joyful Nutritional Launches High-Performance Liposomal Vitamin C and Iron for the Global Supplement Market
  • Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
  • Surging Into High-Performance AI With $AMD Partnership, Patent Expansion, and Strengthened Balance Sheet: Avalon GloboCare Corp. (N A S D A Q: ALBT)
  • The World's First Fully Regenerative Economy: Securing Energy, Food, and a Clean Planet
  • Why Your Berberine Failed: RevGenetics Unveils the Absorption Gap Solution
  • Innovative Environmental Technologies Unveils New Website Featuring Free AI Tools for the Environmental Industry
  • NRx Pharmaceuticals Launches Breakthrough One-Day Treatment Clinic in Florida as FDA Pathway and Clinical Data Strengthen Growth Outlook; $NRXP
  • Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA
  • $167 Billion Pharma R&D Market Largely Untapped by AI Creates Major Growth Runway for KALA Bios Data-Sovereign AI Strategy: N A S D A Q: KALA
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us